In this study, we used ESTIMATE algorithms to estimate the immune and stromal scores of a series of DLBCL tissues from TCGA and GEO databases and analyzed a stromal-immune score-based hub gene, CCL8, for prognosis stratification in DLBCL with clinical specimen validation (Figure 1). This evidence concerns the gene CCL8 and diffuse large B-cell lymphoma.